Gene therapy, despite its potential to cure rare diseases like sickle cell disease, is experiencing a decline in early investor interest, as higher-reward sectors such as obesity and cancer attract more capital. This shift comes as sales for some of the novel gene...
Unveiling a groundbreaking discovery, a team of researchers led by the Feng Zhang at the Broad Institute has discovered a eukaryotic programmable RNA-guided system. Published in the journal Nature, their study unveils a system centered around the Fanzor protein. The...
